Professional Documents
Culture Documents
Insulin Glargine
Insulin Glargine
Insulin Glargine
RESPONSIBILITIES
GENERIC NAME: Lowers blood glucose level by To improve glycemic control in CNS: headache, pyrexia BEFORE:
Insulin Glargine stimulating peripheral glucose adults with diabetes mellitus CV: peripheral edema Administer by subcutaneous
uptake by binding to insulin EENT: pharyngitis, rhinitis injection only in the thigh,
BRAND NAME: receptors on skeletal muscle GI: abdominal pain, abdominal wall, or upper arm.
Toujeo and in fat cells, and by gastroenteritis, nausea, Rotate sites within same region
inhibiting hepatic glucose CONTRAINDICATION: vomiting from one injection to the next
CLASSIFICATION: production; also inhibits Contraindicated during Metabolic: hypoglycemia, to reduce risk of lipodystrophy
Antidiabetic lipolysis and proteolysis, and episodes of hypoglycemia or sodium retention, weight gain
enhances protein synthesis diabetic ketoacidosis Musculoskeletal: back pain Inspect visually for particulate
DOSAGE: Use cautiously in elderly Respiratory: URI, bronchitis, matter and discoloration before
20 “U” patients, who may be at risk cough administration, whenever
for increased sensitivity to Skin: injection-site reactions, solution and container permit;
ROUTE: drugs effects. Signs and lipodystrophy, pruritus, rash use only if solution appears
Subcutaneous symptoms of hypoglycemia Other: allergic reactions, clear and colorless
may be more difficult to flulike symptoms
FREQUENCY: recognize in these patients Instructions for priming and
OD Use cautiously in patients using pens vary from one to
susceptible to hypokalemia another, are very detailed, and
TIMING: such as patients who are involve multiple steps. Refer to
8AM fasting, are taking potassium- manufacturer’s instructions for
lowering drugs, or concurrently use
taking drugs that may affect
potassium level DURING:
Monitor patient carefully for
signs and symptoms of
hypoglycemia, especially in
long-standing disease